Acadian Asset Management LLC Seres Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

  • $28.7 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.93 - $2.15 $93,755 - $216,745
100,812 New
100,812 $141,000
Q2 2022

Aug 09, 2022
BUY
$2.7 - $7.62 $355,789 - $1 Million
131,774 New
131,774 $452,000
Q1 2020

May 11, 2020
SELL
$2.64 - $3.82 $11,708 - $16,941
-4,435 Closed
0 $0
Q4 2019

Feb 06, 2020
SELL
$2.99 - $4.42 $24,778 - $36,628
-8,287 Reduced 65.14%
4,435 $16,000
Q3 2019

Nov 07, 2019
BUY
$2.29 - $4.16 $29,133 - $52,923
12,722 New
12,722 $51,000

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email